Bacterial type II toxin-antitoxin systems acting through post-translational modifications
- PMID: 33384857
- PMCID: PMC7758455
- DOI: 10.1016/j.csbj.2020.12.002
Bacterial type II toxin-antitoxin systems acting through post-translational modifications
Abstract
The post-translational modification (PTM) serves as an important molecular switch mechanism to modulate diverse biological functions in response to specific cues. Though more commonly found in eukaryotic cells, many PTMs have been identified and characterized in bacteria over the past decade, highlighting the importance of PTMs in regulating bacterial physiology. Several bacterial PTM enzymes have been characterized to function as the toxin component of type II TA systems, which consist of a toxin that inhibits cell growth and an antitoxin that protects the cell from poisoning by the toxin. While TA systems can be classified into seven types based on nature of the antitoxin and its activity, type II TA systems are perhaps the most studied among the different TA types and widely distributed in eubacteria and archaea. The type II toxins possessing PTM activities typically modify various cellular targets mostly associated with protein translation and DNA replication. This review mainly focuses on the enzymatic activities, target specificities, antitoxin neutralizing mechanisms of the different families of PTM toxins. We also proposed that TA systems can be conceptually viewed as molecular switches where the 'on' and 'off' state of the system is tightly controlled by antitoxins and discussed the perspective on toxins having other physiologically roles apart from growth inhibition by acting on the nonessential cellular targets.
Keywords: ADP-ribosylation; AMPylation; Acetylation; Persistence; Phosphorylation; TA system.
© 2020 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Novel toxins from type II toxin-antitoxin systems with acetyltransferase activity.Plasmid. 2017 Sep;93:30-35. doi: 10.1016/j.plasmid.2017.08.005. Epub 2017 Sep 20. Plasmid. 2017. PMID: 28941941 Review.
-
RNA Regulated Toxin-Antitoxin Systems in Pathogenic Bacteria.Front Cell Infect Microbiol. 2021 May 18;11:661026. doi: 10.3389/fcimb.2021.661026. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34084755 Free PMC article. Review.
-
Toxin-antitoxin systems and their medical applications: current status and future perspective.Appl Microbiol Biotechnol. 2021 Mar;105(5):1803-1821. doi: 10.1007/s00253-021-11134-z. Epub 2021 Feb 13. Appl Microbiol Biotechnol. 2021. PMID: 33582835 Review.
-
Keeping the Wolves at Bay: Antitoxins of Prokaryotic Type II Toxin-Antitoxin Systems.Front Mol Biosci. 2016 Mar 22;3:9. doi: 10.3389/fmolb.2016.00009. eCollection 2016. Front Mol Biosci. 2016. PMID: 27047942 Free PMC article. Review.
-
The Variety in the Common Theme of Translation Inhibition by Type II Toxin-Antitoxin Systems.Front Genet. 2020 Apr 17;11:262. doi: 10.3389/fgene.2020.00262. eCollection 2020. Front Genet. 2020. PMID: 32362907 Free PMC article. Review.
Cited by
-
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.Pathogens. 2023 Feb 2;12(2):240. doi: 10.3390/pathogens12020240. Pathogens. 2023. PMID: 36839512 Free PMC article.
-
Structural insights into the PrpTA toxin-antitoxin system in Pseudoalteromonas rubra.Front Microbiol. 2022 Nov 24;13:1053255. doi: 10.3389/fmicb.2022.1053255. eCollection 2022. Front Microbiol. 2022. PMID: 36504814 Free PMC article.
-
Phosphorylation of VapB antitoxins affects intermolecular interactions to regulate VapC toxin activity in Mycobacterium tuberculosis.J Bacteriol. 2024 Oct 24;206(10):e0023324. doi: 10.1128/jb.00233-24. Epub 2024 Sep 24. J Bacteriol. 2024. PMID: 39315797 Free PMC article.
-
Phosphorylation of VapB antitoxins affects intermolecular interactions to regulate VapC toxin activity in Mycobacterium tuberculosis.bioRxiv [Preprint]. 2024 May 30:2024.05.30.596101. doi: 10.1101/2024.05.30.596101. bioRxiv. 2024. Update in: J Bacteriol. 2024 Oct 24;206(10):e0023324. doi: 10.1128/jb.00233-24. PMID: 38853858 Free PMC article. Updated. Preprint.
-
Effect of Pefloxacin on Clostridioides difficile R20291 Persister Cells Formation.Antibiotics (Basel). 2025 Jun 20;14(7):628. doi: 10.3390/antibiotics14070628. Antibiotics (Basel). 2025. PMID: 40723930 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous